Abstract
This comprehensive evaluation of the blood industry provides an analysis of
all the key market segments involved in this industry, including blood
products such as:
- Red Blood Cells (RBCs)
- Immunoglobulins
- Albumin
- Other Plasma Products
- Synthetic HBOC and PFC Agents
- Recombinant Factors
And blood supply management products, including:
- Blood Collection Equipment
- Automated Blood Collection Equipment
- Blood Banking and Plasmapheresis Testing
- Blood Typing
- Human Immunodeficiency Virus (HIV) Testing
- Hepatitis A Virus Testing
- Hepatitis B Virus Testing
- Hepatitis C Virus Testing
- Human T-Cell Leukemia Virus Testing
- West Nile Virus Testing
- Other Safety Testing
In addition to complete market data, including forecasts to 2012, the study
reports
- Product demand estimates by region
- Collection and transfusion estimates
- High-blood-loss procedure estimates
- Product pricing
- Reimbursement rates
- Epidemiology of key conditions requiring blood products
- Products on the market and in development
The report also provides discussions of the key trends, as well as the
regulatory, business, and clinical challenges facing the various sectors;
profiles of 25 major players in the industry are included.
Historical information for this report was gathered from a wide variety of
published sources including company reports and filings, government documents,
legal filings, trade journals, newspapers and business press, analysts'
reports and other sources. Primary interviews and correspondence with company
representatives were conducted to capture the perspectives from industry
participants' point of view and assess trends, and form the basis of the
forecasting and competitive analysis.
View Cart
